These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20712775)

  • 1. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients.
    Persons DA
    Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J; Persons DA
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on gene therapy for hemoglobin disorders.
    Persons DA
    Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus vectors in β-thalassemia.
    Payen E; Colomb C; Negre O; Beuzard Y; Hehir K; Leboulch P
    Methods Enzymol; 2012; 507():109-24. PubMed ID: 22365771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
    Hanazono Y; Terao K; Ozawa K
    Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Boulad F; Rivière I; Sadelain M
    Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.
    Sadelain M; Rivière I; Wang X; Boulad F; Prockop S; Giardina P; Maggio A; Galanello R; Locatelli F; Yannaki E
    Ann N Y Acad Sci; 2010 Aug; 1202():52-8. PubMed ID: 20712772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
    Yannaki E; Stamatoyannopoulos G
    Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
    May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M
    Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia.
    Zhao HF; Abraham A; Kim YS; Wang YD; Pestina T; Zhan J; Humphries K; Nienhuis AW; Persons DA
    Mol Ther; 2017 Mar; 25(3):593-605. PubMed ID: 28190779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.